Data / Form D filings / IntraBio Inc.
IntraBio Inc.: Form D filings
IntraBio Inc., a biotechnology company in Austin, TX, filed 3 Form D notices with the SEC between 2018 and 2024. The latest, on March 25, 2024, reports $40.3 million sold of a $41 million offering to 37 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 W 5th Street, Suite 1100, Austin, TX, 78701
- Phone
- (843) 720-0000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1730493
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | New notice | $40,999,990 | $40,267,575 | $732,415 | 37 | Nov 7, 2023 | sec.gov |
| Nov 5, 2020 | Amendment | $21,000,000 | $10,300,000 | $10,700,000 | 62 | Jan 26, 2018 | sec.gov |
| Aug 20, 2018 | New notice | $10,000,000 | $4,910,000 | $5,090,000 | 22 | Jan 26, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| TAYLOR C. FIELDS | Executive Officer | |
| CHRISTIAN C. YEGEN | Executive Officer, Director | |
| MALLORY FACTOR | Executive Officer, Director | |
| MARK C. LUBKEMAN | Executive Officer | |
| IAN C. BILLINGTON | Executive Officer | |
| JAMES C. MEYERS | Executive Officer | |
| IAN C. ROSEN | Executive Officer | |
| ALI C. KHAN | Director | |
| ELIZABETH FACTOR | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Mar 25, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IntraBio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.